Navigation Links
Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment

nts who discontinued study therapy in ETV-027, and subsequently restarted treatment in rollover study ETV-901, with a greater than 60 day gap between end of treatment in study ETV-027 and start of treatment in study ETV-901.

    -- ETV-027 compared 0.5 mg of BARACLUDE vs. 100 mg of lamivudine in
nucleoside-naive chronic HBeAg-negative chronic hepatitis B patients.
-- Rollover study ETV-901 was established as an open-label, follow-up
protocol for patients in phase II and III studies of BARACLUDE.
-- Due to ongoing blinding of study ETV-027, most patients retreated in
ETV-901 initially received a combination of 1 mg of BARACLUDE plus 100
mg of lamivudine, and were subsequently switched to 1 mg of BARACLUDE
monotherapy.

The analysis cohort was defined regardless of treatment response at the end of dosing in study ETV-027, and independent of virologic or ALT measurements at the start of dosing in study ETV-901. During off-treatment follow-up, the majority of patients had recurrent levels of hepatitis B virus in the blood (viremia) and increases in ALT.

    Data Results
At the end of dosing for study ETV-027:
-- 94 percent (n=93/99) of the re-treatment cohort had undetectable viral
load
-- 78 percent (n=77/99) had ALT normalization
At entry into ETV-901:
-- Four percent (n=4/99) of patients had undetectable viral load
-- Eight percent (n=8/97) of patients had ALT normalization
Following re-treatment in study ETV-901:
-- 93 percent (n=82/88) of patients had undetectable viral load (HBV DNA
<300 copies/mL) by week 48 of re-treatment with BARACLUDE
-- 83 percent (n=79/95) of patients had ALT normalization (ALT less than
or equal to 1 times the upper limit of normal) by week 48 of re-
treatment BARACLUDE
Adverse events in study ETV-027/901 re-treatment cohort:
-- 67 percent (n=66/99) of patients experienced an adverse event. The most
common adverse events occurring in greater than ten percent of patients
were abdominal pain, fa
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients
2. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
3. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
6. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
7. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
8. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
9. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
10. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
11. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
Post Your Comments:
(Date:5/6/2015)... Delcath Systems, Inc. (NASDAQ: DCTH ), a specialty ... an emphasis on the treatment of primary and metastatic ... ended March 31, 2015.  Highlights of ... Achieved quarterly product revenue of $0.44 million, an increase ... of 2014; , Activated a prospective patient registry ...
(Date:5/6/2015)... Md. , May 6, 2015 The ... that it has finalized agreement with Richard M. ... 2021. "We are very pleased to have ... CEO," said Hal Baseman , the Chair of ... significant success, performance and growth.  Richard has led a ...
(Date:5/6/2015)... , May 06, 2015 Research and ... the addition of the "Global Suture Industry ... The Global Suture Industry Report 2015 is ... state of the suture industry. The ... including definitions, classifications, applications and industry chain structure. ...
Breaking Medicine Technology:Delcath Reports 2015 First Quarter Financial Results 2Delcath Reports 2015 First Quarter Financial Results 3Delcath Reports 2015 First Quarter Financial Results 4Delcath Reports 2015 First Quarter Financial Results 5Delcath Reports 2015 First Quarter Financial Results 6Delcath Reports 2015 First Quarter Financial Results 7Delcath Reports 2015 First Quarter Financial Results 8PDA Extends Richard M. Johnson as President/CEO for Six Additional Years 2Global Suture Industry Report 2015 - Forecast Trends to 2021 2Global Suture Industry Report 2015 - Forecast Trends to 2021 3
... Biodel Inc. (Nasdaq: BIOD ) announced today the ... Officer.  Dr. Steiner is a co-founder of Biodel and will ... served as Biodel,s chairman, president and chief executive officer from ... Errol De Souza was named the company,s president and chief ...
... YORK, Dec. 14, 2010 Reportlinker.com announces ... available in its catalogue: ... & Ablation Devices 2011 ... 2010, the Asia Pacific markets for cardiac ...
Cached Medicine Technology:Biodel Announces Retirement of Dr. Solomon Steiner as Chief Scientific Officer 2Biodel Announces Retirement of Dr. Solomon Steiner as Chief Scientific Officer 3Biodel Announces Retirement of Dr. Solomon Steiner as Chief Scientific Officer 4Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 2Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 3Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 4Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 5Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 6Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 7Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 8Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 9Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 10Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 11Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 12Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 13Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 14Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 15Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 16Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 17Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 18Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 19Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 20Reportlinker Adds Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 21
(Date:5/6/2015)... Imprivata ® (NYSE: IMPR), the healthcare ... will lead a discussion about the Internet of Things ... authentication challenges, during Citrix Synergy (May 12-14, ... the benefits of creating a network of IP-connected computers, ... can share information. It will also emphasize the importance ...
(Date:5/6/2015)... Experienced Vancouver air conditioning installation and repair ... will now conduct their cooling services, including air conditioning ... commercial and residential units. Strata complex air conditioning services ... technical knowledge as well as a professionally trained staff. ... take away any old air conditioning unit to be ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Baptist ... are the first in north Florida and southeast ... is the latest innovation in total hip replacement ... advanced, surgeon-controlled robotic arm that enables the accurate ... Center Jacksonville has offered MAKOplasty® partial knee resurfacing ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Is Colorado’s ... , Next month the Centennial State will mark the ... cannabis sales to adults. And while Colorado’s legal marijuana ... during that time, it’s also facing some new challenges. ... are currently facing shortages, especially in the wake of ...
(Date:5/6/2015)... Vancouver Chiropractic Clinic, Backs in ... blog containing the Canadian Physical Activity and Sedentary ... for Exercise Physiology (CSEP). Since the CSEP is ... fitness research and personal training in Canada, its ... beneficial and a rich resource for many people. ...
Breaking Medicine News(10 mins):Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 3Health News:Vancouver Chiropractor Shares Canadian Physical Activity and Sedentary Behavior Guidelines by CSEP in New Blog 2
... ... emergency medical cache of disposable medical supplies, ready for quick use by patients and ... (PRWEB) ... of preparing for the possibility of a large scale health emergencies. Healthcare organizations need ...
... ... on the addictive nature of junk food along with the facts coming out through books ... ALL ONE supplements, has taken a public stand for good nutrition and a healthy diet. ... & Brian Show," out of Los Angeles. , ...
... ... in - with the apps Rx for a busy life. ,Life gets ... of popular mobile applications for iPhone, iPod touch, and the new IPad ... will make your busy life less stressful, less complicated and yes… more ...
... ... ardent supporter of Primary Children’s, opened his heart and wallet and pledged over $11,000 ... ... Medical Center and KSL NewsRadio recently kicked off their 34th Annual Radiothon to raise ...
... Up to 200 people hit ... , ... 2010-- Up to 200 people hit by Cyclone Tomas in Fiji have been given emergency shelter ... the Vanua Levu and Lau Group islands last month, destroying homes and crops and prompting authorities ...
... ... 2010 that exposed large retailers selling used and returned underwear, Pampered Passions Fine Lingerie has ... , ... One of the Web’s most popular fine lingerie retailers, Pampered Passions Fine Lingerie , ...
Cached Medicine News:Health News:Provide Medical Surge Care with MasCache by DQE 2Health News:Is Our Junk Food Diet Killing America? 2Health News:Is Our Junk Food Diet Killing America? 3Health News:Is Our Junk Food Diet Killing America? 4Health News:Dr. Appz Launches Comprehensive Productivity App for iPhone 2Health News:Thomas E. Mower Makes Generous Donations To Primary Children's Medical Center 2Health News:Thomas E. Mower Makes Generous Donations To Primary Children's Medical Center 3Health News:ShelterBox Aid Sent to Cyclone-Hit Fiji 2Health News:Pampered Passions Fine Lingerie Starts Petition Against Retailers Selling Used Underwear and Lingerie 2
... OCUFLOX® ophthalmic solution is an ... your doctor may instruct you ... an eye infection caused by ... ulcers are the 2 types ...
...
ALPHAGAN® (brimonidine tartrate ophthalmic solution) 0.2% is indicated for lowering IOP in patients with open-angle galucoma or ocular hypertension....
ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.15% is medication in the form of an eye drop that is used to lower the pressure inside your eye(s), also referred to as intraocular pressu...
Medicine Products: